Literature DB >> 8446173

A new component of the transcription factor DRTF1/E2F.

R Girling1, J F Partridge, L R Bandara, N Burden, N F Totty, J J Hsuan, N B La Thangue.   

Abstract

Transcription factor DRTF1/E2F coordinates events in the cell cycle with transcription by its cyclical interactions with important regulators of cellular proliferation like the retinoblastoma tumour-suppressor gene product (Rb) and the Rb-related protein, p107 (refs 1-8). DRTF1/E2F binding sites occur in the control regions of genes involved in proliferation, and both Rb and p107 repress the capacity of DRTF1/E2F to activate transcription (refs 11, 12; M. Zamanian and N.B.L.T., manuscript submitted). Mutant Rb proteins isolated from tumour cells are unable to bind DRTF1/E2F (refs 11-13), and certain viral oncoproteins, such as adenovirus E1A, sequester Rb and p107 in order to free active DRTF1/E2F (refs 5, 11, 12, 14, 15). Here we report the isolation of a complementary DNA encoding DRTF1-polypeptide-1 (DP-1), a major sequence-specific binding protein that is present in DRTF1/E2F, including Rb- and p107-associated DRTF1/E2F. The DNA-binding domain of DP-1 contains a region that resembles that of E2F-1 (refs 16, 17), and recognizes the same sequence. DRTF1/E2F thus appears to contain at least two sequence-specific DNA-binding proteins.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8446173     DOI: 10.1038/362083a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  83 in total

1.  Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals.

Authors:  R Sears; K Ohtani; J R Nevins
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Mutations in Drosophila DP and E2F distinguish G1-S progression from an associated transcriptional program.

Authors:  I Royzman; A J Whittaker; T L Orr-Weaver
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

3.  Differential regulation of E2F1, DP1, and the E2F1/DP1 complex by ARF.

Authors:  Abhishek Datta; Alo Nag; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

4.  ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.

Authors:  Abhishek Datta; Jayita Sen; Jussara Hagen; Chandrashekhar K Korgaonkar; Michael Caffrey; Dawn E Quelle; Douglas E Hughes; Timothy J Ackerson; Robert H Costa; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  Arabidopsis E2F1 binds a sequence present in the promoter of S-phase-regulated gene AtCDC6 and is a member of a multigene family with differential activities.

Authors:  S M de Jager; M Menges; U M Bauer; J A Murra
Journal:  Plant Mol Biol       Date:  2001-11       Impact factor: 4.076

6.  Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.

Authors:  C Liu; N D Sista; J S Pagano
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Positive and negative regulation of cell proliferation by E2F-1: influence of protein level and human papillomavirus oncoproteins.

Authors:  R M Melillo; K Helin; D R Lowy; J T Schiller
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Authors:  M Xu; K A Sheppard; C Y Peng; A S Yee; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

9.  Functional interaction between DP-1 and p53.

Authors:  T S Sørensen; R Girling; C W Lee; J Gannon; L R Bandara; N B La Thangue
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.

Authors:  D Melamed; N Tiefenbrun; A Yarden; A Kimchi
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.